Bosh sahifaOGN • NYSE
add
Organon & Co
6,33 $
Seans yopilganidan keyin:(0,95%)+0,060
6,39 $
Yopilgan:12-mar, 17:56:47 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
6,40 $
Kunlik diapazon
6,27 $ - 6,48 $
Yillik diapazon
6,18 $ - 15,88 $
Bozor kapitalizatsiyasi
1,65 mlrd USD
Oʻrtacha hajm
4,45 mln
Narx/foyda
8,83
Dividend daromadliligi
1,26%
Asosiy maydon
NYSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,51 mlrd | -5,34% |
Joriy xarajat | 522,00 mln | -11,38% |
Sof foyda | -205,00 mln | -288,07% |
Sof foyda marjasi | -13,60 | -298,54% |
Har bir ulushga tushum | 0,63 | -30,00% |
EBITDA | 340,00 mln | -11,46% |
Amaldagi soliq stavkasi | -38,51% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 574,00 mln | -14,96% |
Jami aktivlari | 12,87 mlrd | -1,79% |
Jami passivlari | 12,12 mlrd | -4,07% |
Umumiy kapital | 752,00 mln | — |
Tarqatilgan aksiyalar | 260,32 mln | — |
Narxi/balansdagi bahosi | 2,21 | — |
Aktivlardan daromad | 4,62% | — |
Kapitaldan daromad | 6,33% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -205,00 mln | -288,07% |
Operatsiyalardan naqd pul | 141,00 mln | -63,85% |
Sarmoyadan naqd pul | -65,00 mln | 78,04% |
Moliyadan naqd pul | -187,00 mln | -128,05% |
Naqd pulning sof oʻzgarishi | -98,00 mln | -11,36% |
Boʻsh pul | 64,88 mln | -76,36% |
Haqida
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Tashkil etilgan
1923
Sayt
Xodimlar soni
10 000
